These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17600223)

  • 1. Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis.
    Hauer AD; van Puijvelde GH; Peterse N; de Vos P; van Weel V; van Wanrooij EJ; Biessen EA; Quax PH; Niethammer AG; Reisfeld RA; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):2050-7. PubMed ID: 17600223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against TIE2 reduces atherosclerosis.
    Hauer AD; Habets KL; van Wanrooij EJ; de Vos P; Krueger J; Reisfeld RA; van Berkel TJ; Kuiper J
    Atherosclerosis; 2009 Jun; 204(2):365-71. PubMed ID: 19022447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific anti-glioma angiogenesis immune response induced by attenuated Salmonella typhimurium vaccine expressing vascular endothelial growth factor receptor-2].
    Feng KK; Zhao HY; Qiu H; Chen J
    Ai Zheng; 2005 May; 24(5):548-53. PubMed ID: 15890095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice.
    Petrovan RJ; Kaplan CD; Reisfeld RA; Curtiss LK
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1095-100. PubMed ID: 17303776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
    Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.
    Takahashi H; Ishizaki H; Tahara H; Tamaki Y; Yanagi Y
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2143-7. PubMed ID: 18436847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking adult neovascularization during ischemia and inflammation using Vegfr2-LacZ reporter mice.
    Heidenreich R; Murayama T; Silver M; Essl C; Asahara T; Rocken M; Breier G
    J Vasc Res; 2008; 45(5):437-44. PubMed ID: 18418002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
    Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
    Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic immune reactivity against persisting microbial antigen in the vasculature exacerbates atherosclerotic lesion formation.
    Krebs P; Scandella E; Bolinger B; Engeler D; Miller S; Ludewig B
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2206-13. PubMed ID: 17656668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic immunotherapy targeting Flk-1, DNA vaccine and adoptive T cell transfer, inhibits ocular neovascularization.
    Zhang H; Sonoda KH; Hijioka K; Qiao H; Oshima Y; Ishibashi T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):471-476. PubMed ID: 19340941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; de Vos P; Bixel MG; Vestweber D; van Berkel TJ; Kuiper J
    Cardiovasc Res; 2008 Jun; 78(3):590-6. PubMed ID: 18250143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.
    Reisfeld RA; Niethammer AG; Luo Y; Xiang R
    Immunol Rev; 2004 Jun; 199():181-90. PubMed ID: 15233734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
    Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clément K; Holvoet P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
    Bharat A; Benshoff N; Fleming TP; Dietz JR; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2008 Aug; 110(3):453-63. PubMed ID: 17874294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
    Lu XL; Jiang XB; Liu RE; Zhang SM
    Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.